Supersensitivity of the cholinergic muscarinic system in the rat's brain is induced by high concentrations of Cu+2

Invest Clin. 2002 Jun;43(2):107-17.

Abstract

Transition metals have been described as regulators of receptor's function. here, we studied the effects of chronic administration of Cu2+ or the Cu2+ chelator penicillamine (PA) on the functional and binding properties of the muscarinic receptors (MR) on selected areas of rat's brain. Groups of 10 Sprague-Dawley rats were treated daily, for 45 days with either 1) 1 mg/Kg CuSO4 (Cu2+), 2) 100 mg/Kg PA, or 3) saline solution. Double T-maze and motility cages were used for behavioral testing and the binding assays were performed using [3H]-QNB or [3H]-N-MSCP as MR's ligands. Cu2+ brain levels were measured in the cerebral cortex by atomic absorption spectrophotometer. Results showed that PA treated rats displayed a significant decrease of locomotor's activity (LA) and rearing behavior (RB), but a significant increases in memory efficiency (ME). Cu2+ treated rats displayed diminished RB with no significant changes in LA. Cu2+ treated rats displayed higher MR's density (Bmax) in cortex (C), striatum (S), and hippocampus (H). An increase in Bmax was also observed in PA treated rats, but only in C and S. Finally, Cu2+ tissue concentration was significantly higher in C of both Cu2+ and with PA treated animals. In conclusion, 45 days of Cu2+ or PA treatment induced brain hypercuprosis, which was associated with MR binding supersensitivity; however, change in ME was only observed in PA treated rats suggesting that might be still another factor in these experiments besides Cu2+ (i.e., Zn2+ or PA itself) involved in memory modulation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Atropine / pharmacology
  • Brain Chemistry / drug effects*
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism
  • Chelating Agents / pharmacology
  • Cholinergic Fibers / drug effects
  • Cholinergic Fibers / physiology
  • Copper Sulfate / administration & dosage
  • Copper Sulfate / pharmacology*
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism
  • Dose-Response Relationship, Drug
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Male
  • Maze Learning / drug effects
  • Memory / drug effects
  • Motor Activity / drug effects
  • Muscarinic Agonists / pharmacology
  • Muscarinic Antagonists / pharmacology
  • Nerve Tissue Proteins / drug effects*
  • Penicillamine / pharmacology
  • Pyridoxine / pharmacology
  • Quinuclidinyl Benzilate / pharmacology
  • Radioligand Assay
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Muscarinic / drug effects*
  • Receptors, Muscarinic / metabolism
  • Zinc Sulfate / pharmacology

Substances

  • Chelating Agents
  • Muscarinic Agonists
  • Muscarinic Antagonists
  • Nerve Tissue Proteins
  • Receptors, Muscarinic
  • quinuclidinyl benzilate receptor
  • Quinuclidinyl Benzilate
  • Zinc Sulfate
  • Atropine
  • Penicillamine
  • Pyridoxine
  • Copper Sulfate